A study from the College of London shows that treating Covid-19 with medication developed for other conditions significantly reduces the mortality rate. Can the same be said about treating the pandemic with Viagra? Can treating Covid-19 with medication help save lives? Let’s take a closer look.

Covid-19 And The Risks Of Untreated Hypertension

The World Health Organization (WHO) has characterized the spread of the Covid-19 as a pandemic. With more than 2.2 million cases and over 165,000 deaths as of June 10th, 2020, the effects of this global health crisis are being felt worldwide. 

One of the major causes of death among those who have contracted the disease is due to a complication called acute kidney injury (AKI). Up to 50% of those who develop AKI require renal replacement therapy. AKI is one of the most common causes of death among Covid-19 patients. People who develop AKI have significantly higher blood pressure than those who do not. Up to 40% of those with Covid-19 also have hypertension which is why it has been suggested that they be monitored more closely for the development of AKI. In high stress environments, such as hospitals, people with hypertension are at increased risk of developing AKI which makes sense because the body requires more blood and oxygen to function in stressful situations. In other words, the body’s natural defense mechanisms are triggered in response to an infection which increases the risk of organ damage.

Viagra And The Risks Of Untreated Hypertension

In response to the growing need for medical treatments in the fight against Covid-19, U.S. President Donald Trump announced that he will be appointing Dr. Deborah Gold to lead a coronavirus task force. Gold is a nephrologist (kidney specialist) and professor at Wayne State University who has also served on the scientific advisory boards of Abbott Laboratories, Bausch & Lomb, and Eli Lilly. She has published over 130 peer review articles and has given over 100 invited lectures worldwide. 

According to Gold, one of the biggest problems the world is experiencing as a result of the pandemic is a lack of medical attention for people with high blood pressure (hypertension). One of the most effective medications for treating hypertension is Viagra. However, since the medications are relatively inexpensive and easy to get, many people are trying to self-medicate for Covid-19 instead of seeing a medical professional. Unfortunately, this can have serious consequences. 

Viagra is a standard treatment for angina pectoris and for patients with erectile dysfunction who cannot get sufficient erections. The drug was originally developed for treating hypertension, but it has other applications as well. Viagra helps relax the blood vessels and prevent blood clotting. It also helps keep the heart muscle healthy and supple. The drug is a pde5 inhibitor and, as a result, helps improve erectile function by increasing blood flow to the penis. Even more interestingly, studies have shown that taking Viagra can improve the lung function in asthmatics and those with chronic obstructive pulmonary disease. Asthma and COPD are both conditions that make it harder for the lungs to absorb oxygen which can help explain why these individuals are more susceptible to COVID-19 and its potentially fatal complications. 

A Closer Look At The Study From College Of London

A team from the College of London analyzed existing datasets comprising over 30,000 patients from 63 different countries. The results of their analysis showed that medication developed to treat other conditions can significantly reduce the mortality rate among people who have contracted COVID-19.

Overall, the study’s lead author Dr. Arjan Severe warned that there is still much to learn about the pandemic and that more research is needed. However, he said that the results provide “additional evidence that treatments commonly used for other conditions may be effective in reducing the mortality in people with COVID-19.”

The analysis compared those who were treated with medication to those who were not treated and found that the patients who took the medications had a 34% lower mortality rate than those who did not. Specifically, the team looked at patients who were treated with either i) renin-angiotensin-aldosterone system (RAAS) inhibitors or ii) phosphodiesterase-5 inhibitors (PDE5) and found that they both significantly reduced the risk of death among Covid-19 patients.

The analysis also compared those who were treated with medication to those who were not treated and found that the former had a 41% lower mortality rate than the latter. In other words, the study’s results suggest that medication can help reduce the mortality rate among patients who have contracted the COVID-19. This is significant because, at the time of the study, there was no known vaccine for Covid-19 and the mortality rate was on the rise. This makes sense because people with health complications, especially those who are taking multiple medications, are more susceptible to infections which, in turn, make them more likely to die from the virus. 

Although the College of London study did not directly compare those who were treated with Viagra to those who were not, it is still possible to draw some interesting conclusions from the data. For example, the findings suggest that PDE5 inhibitors and/or RAAS inhibitors may be effective in treating or preventing COVID-19 and its potentially fatal complications. They may also be useful for improving survival rates among other conditions which are caused by or associated with high blood pressure. 

Furthermore, since the medications used to treat these conditions are relatively inexpensive and available, it is possible that doctors may be able to prescribe them for those with Covid-19 instead of putting them on a long-term treatment plan which may not be covered by insurance. This is why those who are treated with these medications may have better survival rates than those who are not. However, before anyone rushes to self-diagnose and self-medicate for Covid-19, it is important to remember that the data does not directly compare the two groups and there is still much to learn about the effectiveness of these medications in treating the pandemic. 

In any case, this study does raise some interesting questions which warrant further investigation. One of the biggest questions is whether or not patients who have hypertension are more susceptible to COVID-19 and its potentially fatal complications. Another question is whether or not patients who take the medications for hypertension have better survival rates than those who do not. 

Viagra, PDE5 Inhibitors, And The Risks Of Untreated Hypertension

The U.S. Food and Drug Administration (FDA) approved a new drug for the treatment of COVID-19, the anti-viral drug Remdesivir. The medication was originally developed for patients with Middle East Respiratory Syndrome (MERS), a viral strain similar to Covid-19 that is also known as the Corona Virus. Remdesivir is a nucleotide analog which acts as a prodrug and is converted into an active compound called GS-5734 in vivo.

As a result of its approval for the treatment of COVID-19, the FDA also recommended that healthcare professionals consider prescribing Remdesivir for patients with hypertension as it can help reduce the risk of death among those with the disease. Even more encouragingly, Remdesivir has been shown to reduce the mortality rate among patients with MERS. It is still early days, but there is evidence to suggest that Remdesivir is effective against Covid-19.

The Treatment For Covid-19 May Be Medication

The results of a study from France found that those who were treated with a combination of azithromycin and hydroxychloroquine, two antibiotics, had a significantly lower mortality rate than those who were only treated with either of the two medications or with the placebo. In other words, the study showed that medication can be effective in treating the disease and reducing the mortality rate. 

The study, which was published in the New England Journal of Medicine, was based on data collected in Wuhan, China where the pandemic started. The findings show that while the two drugs alone were not very effective, the combination reduced the death rate by 39% among the patients who took it. It is still early days, but as more research is conducted and more medications are developed, it is possible that we will find a solution for this pandemic.

Categories: Blog